GOSH researchers, working with international collaborators, have shown that a new gene therapy has long term benefits for children with the severe immune disorder, Wiskott-Aldrich syndrome.
For the first time, patients at Great Ormond Street Hospital and Southampton Children’s Hospital who are aged 12-17 years and immunocompromised are taking part in research to work out how they respond to COVID-19 vaccination.
The world’s largest study of the genetics of critical Covid-19 involving more than 57,000 people, and many of our patients at GOSH, has revealed fresh details about some of the biological mechanisms behind the severe form of the disease.
To mark the International Women's Day, we spoke with YPAG members, Alex, Parveen, Lydia and Hannah, about their involvement in our group and their future science careers.